Related references
Note: Only part of the references are listed.Development of a pre-glycoengineered CHO-K1 host cell line for the expression of antibodies with enhanced Fc mediated effector function
Oliver Popp et al.
MABS (2018)
Next generation antibody drugs: pursuit of the 'high-hanging fruit'
Paul J. Carter et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
The Marburgvirus-Neutralizing Human Monoclonal Antibody MR191 Targets a Conserved Site to Block Virus Receptor Binding
Liam B. King et al.
CELL HOST & MICROBE (2018)
Correlative microscopy for structural microbiology
Stuart C. Howes et al.
CURRENT OPINION IN MICROBIOLOGY (2018)
Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates
Kristen E. Pascal et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults
Martin R. Gaudinski et al.
PLOS MEDICINE (2018)
Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy
Juan C. Almagro et al.
FRONTIERS IN IMMUNOLOGY (2018)
Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection
Erica Ollmann Saphire et al.
CELL (2018)
A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus
Bronwyn M. Gunn et al.
CELL HOST & MICROBE (2018)
Genetic variation of human neutrophil Fcγ receptors and SIRPα in antibody-dependent cellular cytotoxicity towards cancer cells
Louise W. Treffers et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2018)
Beyond binding: antibody effector functions in infectious diseases
Lenette L. Lu et al.
NATURE REVIEWS IMMUNOLOGY (2018)
A Review of Obinutuzumab (GA101), a Novel Type II Anti-CD20 Monoclonal Antibody, for the Treatment of Patients with B-Cell Malignancies
Kensei Tobinai et al.
ADVANCES IN THERAPY (2017)
Correlated fluorescence microscopy and cryo-electron tomography of virus-infected or transfected mammalian cells
Cheri M. Hampton et al.
NATURE PROTOCOLS (2017)
Systems serology for evaluation of HIV vaccine trials
Margaret E. Ackerman et al.
IMMUNOLOGICAL REVIEWS (2017)
Mechanisms of anaphylaxis in human low-affinity IgG receptor locus knock-in mice
Caitlin M. Gillis et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Considering aspects of the 3Rs principles within experimental animal biology
Lynne U. Sneddon et al.
JOURNAL OF EXPERIMENTAL BIOLOGY (2017)
How to turn competitors into collaborators
Erica Ollmann Saphire et al.
NATURE (2017)
Different features of Vδ2 T and NK cells in fatal and non-fatal human Ebola infections
Eleonora Cimini et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Anna Bootz et al.
PLOS PATHOGENS (2017)
Antibody therapies for the prevention and treatment of viral infections
Georgina Salazar et al.
NPJ VACCINES (2017)
Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In Vivo
Joshua A. Horwitz et al.
CELL (2017)
Beyond Viral Neutralization
George K. Lewis et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2017)
Structural Insights into the Niemann-Pick C1 (NPC1)-Mediated Cholesterol Transfer and Ebola Infection
Xin Gong et al.
CELL (2016)
Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection
Carole J. Henry Dunand et al.
CELL HOST & MICROBE (2016)
Harnessing Fc receptor biology in the design of therapeutic antibodies
Peter Sondermann et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth
Jinghe Huang et al.
IMMUNITY (2016)
Utilizing complement evasion strategies to design complement-based antibacterial immunotherapeutics: Lessons from the pathogenic Neisseriae
Sanjay Ram et al.
IMMUNOBIOLOGY (2016)
Translating Inhibitory Fc Receptor Biology into Novel Therapeutic Approaches
Falk Nimmerjahn
JOURNAL OF CLINICAL IMMUNOLOGY (2016)
Structural basis of potent Zika-dengue virus antibody cross-neutralization
Giovanna Barba-Spaeth et al.
NATURE (2016)
A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection
Richard T. Davey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody
Davide Corti et al.
SCIENCE (2016)
Structural and molecular basis for Ebola virus neutralization by protective human antibodies
John Misasi et al.
SCIENCE (2016)
A Novel Platform for the Potentiation of Therapeutic Antibodies Based on Antigen-Dependent Formation of IgG Hexamers at the Cell Surface
Rob N. de Jong et al.
PLOS BIOLOGY (2016)
Correction: Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination
Alison E. Mahan et al.
PLoS Pathogens (2016)
Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination
Alison E. Mahan et al.
PLOS PATHOGENS (2016)
Structures of Ebola virus GP and sGP in complex with therapeutic antibodies
Jesper Pallesen et al.
NATURE MICROBIOLOGY (2016)
Structural Basis for Marburg Virus Neutralization by a Cross-Reactive Human Antibody
Takao Hashiguchi et al.
CELL (2015)
Mechanism of Human Antibody-Mediated Neutralization of Marburg Virus
Andrew I. Flyak et al.
CELL (2015)
Immunology and evolvement of the adenovirus prime, MVA boost Ebola virus vaccine
Yan Zhou et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
Obinutuzumab: A Review of Its Use in Patients with Chronic Lymphocytic Leukaemia
Sheridan M. Hoy
DRUGS (2015)
Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice
Erwin M. Lee et al.
HAEMATOLOGICA (2015)
The role of Fc-FcγR interactions in IgG-mediated microbial neutralization
Stylianos Bournazos et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies
Edgar Davidson et al.
JOURNAL OF VIROLOGY (2015)
Antibody responses to envelope glycoproteins in HIV-1 infection
Dennis R. Burton et al.
NATURE IMMUNOLOGY (2015)
Swift antibodies to counter emerging viruses
Dennis R. Burton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus
Davide Corti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Immune correlates of vaccine protection against HIV-1 acquisition
Lawrence Corey et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice
Erwin M. Lee et al.
HAEMATOLOGICA (2015)
A phase 1 dose-escalation study of XmAb®2513 in patients with relapsed or refractory Hodgkin lymphoma
Anita Kumar et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
pH-dependent Binding Engineering Reveals an FcRn Affinity Threshold That Governs IgG Recycling
M. Jack Borrok et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Identification of antibody glycosylation structures that predict monoclonal antibody Fc-effector function
Amy W. Chung et al.
AIDS (2014)
Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity
Stylianos Bournazos et al.
CELL (2014)
Role of Fc-mediated antibody function in protective immunity against HIV-1
George K. Lewis
IMMUNOLOGY (2014)
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
Xiangguo Qiu et al.
NATURE (2014)
Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge
Daphne A. Stanley et al.
NATURE MEDICINE (2014)
Boosting ADCC and CDC activity by Fc engineering and evaluation of antibody effector functions
Christian Kellner et al.
METHODS (2014)
Structures of protective antibodies reveal sites of vulnerability on Ebola virus
Charles D. Murin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Complement Is Activated by IgG Hexamers Assembled at the Cell Surface
Christoph A. Diebolder et al.
SCIENCE (2014)
Contribution of human FcγRs to disease with evidence from human polymorpnisms and transgenic animal studies
Caitlin Gillis et al.
FRONTIERS IN IMMUNOLOGY (2014)
Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity
Margaret E. Ackerman et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
The Fc-engineered CD19 antibody MOR208 (XmAb5574) induces natural killer cell-mediated lysis of acute lymphoblastic leukemia cells from pediatric and adult patients
C. Kellner et al.
LEUKEMIA (2013)
Cross-neutralization of four paramyxoviruses by a human monoclonal antibody
Davide Corti et al.
NATURE (2013)
Therapeutic Intervention of Ebola Virus Infection in Rhesus Macaques with the MB-003 Monoclonal Antibody Cocktail
James Pettitt et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Isotype and glycoform selection for antibody therapeutics
Roy Jefferis
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2012)
Ebola virus entry requires the host-programmed recognition of an intracellular receptor
Emily Happy Miller et al.
EMBO JOURNAL (2012)
Benralizumab - a humanized mAb to IL-5Rα with enhanced antibody-dependent cell-mediated cytotoxicity - a novel approach for the treatment of asthma
Aasia Ghazi et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody
Seung Y. Chu et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Marketing approval of mogamulizumab A triumph for glyco-engineering
Alain Beck et al.
MABS (2012)
Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond
P. Mark Hogarth et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Mouse model recapitulating human Fcγ receptor structural and functional diversity
Patrick Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease
John M. Dye et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques
Gene Garrard Olinger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions
Ruklanthi de Alwis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Ebola GP-Specific Monoclonal Antibodies Protect Mice and Guinea Pigs from Lethal Ebola Virus Infection
Xiangguo Qiu et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Antigenic Subversion: A Novel Mechanism of Host Immune Evasion by Ebola Virus
Gopi S. Mohan et al.
PLOS PATHOGENS (2012)
The role of differential IgG glycosylation in the interaction of antibodies with FcγRs in vivo
Robert M. Anthony et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2011)
Antibody-Mediated Coengagement of FcγRIIb and B Cell Receptor Complex Suppresses Humoral Immunity in Systemic Lupus Erythematosus
Holly M. Horton et al.
JOURNAL OF IMMUNOLOGY (2011)
Advances in the assessment and control of the effector functions of therapeutic antibodies
Xu-Rong Jiang et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant
Larry Zeitlin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins
Davide Corti et al.
SCIENCE (2011)
Dual Functional Monoclonal Antibody PF-04605412 Targets Integrin α5β1 and Elicits Potent Antibody-Dependent Cellular Cytotoxicity
Gang Li et al.
CANCER RESEARCH (2010)
A Forward Genetic Strategy Reveals Destabilizing Mutations in the Ebolavirus Glycoprotein That Alter Its Protease Dependence during Cell Entry
Anthony C. Wong et al.
JOURNAL OF VIROLOGY (2010)
Biochemical and Structural Characterization of Cathepsin L-Processed Ebola Virus Glycoprotein: Implications for Viral Entry and Immunogenicity
Chantelle L. Hood et al.
JOURNAL OF VIROLOGY (2010)
Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms
Devon J. Shedlock et al.
VIROLOGY (2010)
The impact of Fc engineering on an anti-CD19 antibody: increased Fcγ receptor affinity enhances B-cell clearing in nonhuman primates
Jonathan Zalevsky et al.
BLOOD (2009)
Production of therapeutic antibodies with controlled fucosylation
Naoko Yamane-Ohnuki et al.
MABS (2009)
Mucosal Immunization of Cynomolgus Macaques with the VSVΔG/ZEBOVGP Vaccine Stimulates Strong Ebola GP-Specific Immune Responses
Xiangguo Qiu et al.
PLOS ONE (2009)
Complex of a protective antibody with its Ebola virus GP peptide epitope:: Unusual features of a Vλx light chain
Jeffrey E. Lee et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Optimization of antibody binding to FcγRIIa enhances macrophage phagocytosis of tumor cells
John O. Richards et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor
Jeffrey E. Lee et al.
NATURE (2008)
Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure
Richard Strasser et al.
PLANT BIOTECHNOLOGY JOURNAL (2008)
Generation of biologically contained Ebola viruses
Peter Halfmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Fc gamma receptors as regulators of immune responses
Falk Nimmerjahn et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity
Rachel L. Kaletsky et al.
JOURNAL OF VIROLOGY (2007)
Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating fcγ receptors
Jeffrey B. Stavenhagen et al.
CANCER RESEARCH (2007)
Fc receptor but not complement binding is important in antibody protection against HIV
Ann J. Hessell et al.
NATURE (2007)
Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity
Falk Nimmerjahn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The impact of glycosylation on the biological function and structure of human immunoglobulins
James N. Arnold et al.
ANNUAL REVIEW OF IMMUNOLOGY (2007)
Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys
Wendelien B. Oswald et al.
PLOS PATHOGENS (2007)
Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn)
William F. Dall'Acqua et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein
K Schornberg et al.
JOURNAL OF VIROLOGY (2006)
Engineered antibody Fc variants with enhanced effector function
GA Lazar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Glycosylation of recombinant antibody therapeutics
R Jefferis
BIOTECHNOLOGY PROGRESS (2005)
Improved effector functions of a therapeutic monoclonal Lewis Y-specific antibody by glycoform engineering
M Schuster et al.
CANCER RESEARCH (2005)
Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection
K Chandran et al.
SCIENCE (2005)
CD107a as a functional marker for the identification of natural killer cell activity
G Alter et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity
RL Shields et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody
PWHI Parren et al.
JOURNAL OF VIROLOGY (2002)
Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells
AE Hills et al.
BIOTECHNOLOGY AND BIOENGINEERING (2001)
Metabolic control of recombinant protein N-glycan processing in NS0 and CHO cells
KN Baker et al.
BIOTECHNOLOGY AND BIOENGINEERING (2001)
High resolution mapping of the binding site on human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and design of IgG1 variants with improved binding to the FcγR
RL Shields et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Epitopes involved in antibody-mediated protection from Ebola virus
JA Wilson et al.
SCIENCE (2000)
Share Paper
